Mitigating Chronic Respiratory Disease Through the Lens of Multimorbidity
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age30+
SponsorUniversity College, London
About this trial
The investigators aim to evaluate whether it is feasible for healthcare professionals to implement a case-finding tool to identify individuals at high risk for chronic respiratory diseases (CRDs) during routine care for non-communicable diseases (NCDs) in primary healthcare services in Brazil.
The investigators will complete a cross-sectional observational study involving 20 healthcare professionals (physicians, physiotherapists, community health agents, and nurses) from five primary healthcare services who will apply the COLA-6 tool during routine NCD care. A total sample of 1,000 patients is expected. Qualitative interviews will be conducted with healthcare professionals to explore barriers and facilitators to implementing COLA-6 in clinical practice.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
not provided informed consent
clinically unstable in the past month
current pregnancy
active tuberculosis or being on treatment for tuberculosis
Trial population
1. HCPs providing NCD care in PHC services in Brazil. 2. Patients attending for NCD care in PHC services in Brazil.
Trial design
Design model
Case-only
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Barriers and facilitators to implementing the COLA-6 case-finding tool.
Barriers and facilitators to implementing the COLA-6 case-finding tool, assessed at qualitative interviews.
Time frame
At study completion: qualitative interviews will be completed after each HCP has completed 50 uses of COLA-6.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University College, London
Lead sponsor
Universidade Federal de Sao Carlos
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: